Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: double-blind placebo-controlled food challenge (DBPCFC)
DBV Announces Promising 2-Year Results from Ongoing Viaskin “Peanut Patch” Toddler...
News Wire ~ 3rd Party Press Release
-
2023/11/10
81.3% of subjects who completed the oral food challenge reached an eliciting dose of ≥1,000 mg after 24 months of treatment.
Intrommune’s Peanut Allergy Toothpaste Therapy Reaches Phase 1 Clinical Trial Milestone
Dave Bloom
-
2023/07/27
The process known as Oral Mucosal Immunotherapy does not involve ingesting the allergen.
FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...
Dave Bloom
-
2022/12/26
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut...
Dave Bloom
-
2022/11/17
According to research presented at this year's #ACAAI22 meeting.
Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment
Dave Bloom
-
2022/10/28
Company is developing a patient-friendly treatment platform for peanut and other food allergies.
Viaskin Peanut Completes Phase III Part A Study of Toddlers With...
News Wire ~ 3rd Party Press Release
-
2018/09/12
Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.